Epidermal growth factor receptor-Targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently

20Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

AIM To compare the capacity of newly developed epidermal growth factor receptor (EGFR)-Targeted immune magnetic liposomes (EILs) vs epithelial cell adhesion molecule (EpCAM) immunomagnetic beads to capture colorectal circulating tumor cells (CTCs). METHODS EILs were prepared using a two-step method, and the magnetic and surface characteristics were confirmed. The efficiency of capturing colorectal CTCs as well as the specificity were compared between EILs and EpCAM magnetic beads. RESULTS The obtained EILs had a lipid nanoparticle structure similar to cell membrane. Improved binding with cancer cells was seen in EILs compared with the method of coupling nano/microspheres with antibody. The binding increased as the contact time extended. Compared with EpCAM immunomagnetic beads, EILs captured more CTCs in peripheral blood from colorectal cancer patients. The captured cells showed consistency with clinical diagnosis and pathology. Mutation analysis showed same results between captured CTCs and cancer tissues. CONCLUSION EGFR antibody-coated magnetic liposomes show high efficiency and specificity in capturing colorectal CTCs.

Cite

CITATION STYLE

APA

Kuai, J. H., Wang, Q., Zhang, A. J., Zhang, J. Y., Chen, Z. F., Wu, K. K., & Hu, X. Z. (2018). Epidermal growth factor receptor-Targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently. World Journal of Gastroenterology, 24(3), 351–359. https://doi.org/10.3748/wjg.v24.i3.351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free